Here's the live share price of Pfizer along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Over the last 5 years, the share price of Pfizer has gained 0.62% CAGR. Over the past year, the corresponding return has been -13.17%.
Pfizer’s current P/E of 29.18x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our High Priced stocks Screener.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
---|---|---|---|---|---|---|---|
Pfizer | 0.31 | -10.46 | -12.00 | 25.98 | -12.94 | 7.16 | 0.62 |
Sun Pharmaceutical Industries | 1.08 | -1.32 | -2.30 | -5.58 | -13.67 | 22.86 | 25.44 |
Divi's Laboratories | 0.84 | -1.39 | -6.98 | 7.26 | 11.48 | 19.38 | 13.39 |
Cipla | -0.48 | -0.53 | 3.50 | 4.23 | -6.88 | 14.18 | 15.63 |
Torrent Pharmaceuticals | -1.63 | -3.25 | 8.69 | 15.50 | 2.40 | 33.75 | 19.96 |
Dr. Reddy's Laboratories | 0.49 | 3.70 | -0.64 | 13.92 | -1.18 | 17.09 | 7.19 |
Mankind Pharma | -1.56 | 3.97 | 9.17 | 18.23 | 4.67 | 21.72 | 12.52 |
Zydus Lifesciences | -0.55 | 4.77 | 7.79 | 15.71 | -6.91 | 42.05 | 21.62 |
Lupin | 3.72 | 4.15 | 5.54 | 3.02 | -9.66 | 48.04 | 14.81 |
Abbott India | -0.88 | -4.93 | -2.46 | 2.81 | 7.44 | 20.90 | 13.41 |
Alkem Laboratories | 3.56 | 3.02 | 14.49 | 14.40 | -11.41 | 20.01 | 14.29 |
Aurobindo Pharma | 3.96 | 0.18 | -1.58 | -1.88 | -29.64 | 26.95 | 5.60 |
Glenmark Pharmaceuticals | -2.57 | 5.17 | 25.57 | 45.12 | 21.20 | 77.31 | 32.95 |
Laurus Labs | -0.17 | 3.44 | 35.51 | 53.95 | 78.57 | 20.10 | 27.14 |
Biocon | -1.06 | -1.13 | 2.14 | 7.85 | -4.10 | 7.35 | -3.86 |
Anthem Biosciences | 1.87 | 3.75 | 13.75 | 13.75 | 13.75 | 4.39 | 2.61 |
GlaxoSmithKline Pharmaceuticals | -3.13 | -1.60 | -15.60 | 1.95 | -1.96 | 24.23 | 9.16 |
Cohance Lifesciences | -0.02 | 10.08 | -0.30 | -12.87 | -14.37 | 28.96 | 21.52 |
Gland Pharma | 6.20 | 2.52 | 15.71 | 30.13 | 9.43 | -4.11 | 2.12 |
Ipca Laboratories | -0.22 | -5.32 | -3.38 | -0.34 | -9.99 | 14.97 | 3.52 |
Over the last one year, Pfizer has declined 12.94% compared to peers like Sun Pharmaceutical Industries (-13.67%), Divi's Laboratories (11.48%), Cipla (-6.88%). From a 5 year perspective, Pfizer has underperformed peers relative to Sun Pharmaceutical Industries (25.44%) and Divi's Laboratories (13.39%).
Day | SMA | EMA |
---|---|---|
5 | 5,144.18 | 5,173.35 |
10 | 5,143.69 | 5,183.84 |
20 | 5,312.14 | 5,220.64 |
50 | 5,333.71 | 5,264.07 |
100 | 5,216.99 | 5,181.61 |
200 | 4,898.13 | 5,054.08 |
In the latest quarter, Pfizer remained same as its previous close in promoter holding, while DII stake increased to 17.23%, FII holding rose to 2.40%, and public shareholding moved down to 16.45% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
---|---|---|---|
Nippon India Small Cap Fund | 12,06,103 | 0.96 | 621.87 |
Quant Small Cap Fund | 8,75,027 | 1.57 | 451.16 |
Nippon India Multi Cap Fund | 3,62,848 | 0.4 | 187.08 |
Nippon India Pharma Fund | 3,18,249 | 1.96 | 164.09 |
UTI Mid Cap Fund | 2,56,539 | 1.13 | 132.27 |
ICICI Prudential Smallcap Fund | 2,30,000 | 1.4 | 118.59 |
DSP Healthcare Fund | 2,00,644 | 3.33 | 103.45 |
ICICI Prudential Pharma Healthcare & Diagnostics (P.H.D) Fund | 1,80,970 | 1.51 | 93.31 |
DSP Equity Opportunities Fund | 1,78,101 | 0.6 | 91.83 |
Aditya Birla Sun Life MNC Fund - Div | 1,53,670 | 2.13 | 79.23 |
Price | (%) As on Invalid Date IST |
Open Interest | (%) |
High | |
Low | |
Open | |
Close | |
Contract Traded | |
Turnover (in lakhs) |
Date Time | Announcement |
---|---|
Aug 13, 2025, 10:34 PM IST | Pfizer Ltd. - Board Meeting Outcome for Outcome Of Board Meeting - Unaudited Financial Results For The Quarter Ended June 30, |
Aug 13, 2025, 10:29 PM IST | Pfizer Ltd. - Outcome Of Board Meeting - Unaudited Financial Results For The Quarter Ended June 30, 2025 Held Today, August 1 |
Aug 12, 2025, 12:51 AM IST | Pfizer Ltd. - Announcement under Regulation 30 (LODR)-Press Release / Media Release |
Aug 12, 2025, 12:37 AM IST | Pfizer Ltd. - Launch Of Pneumococcal Polysaccharide Conjugate Vaccine (Adsorbed) I.P., 20 - Valent (PCV20) |
Aug 07, 2025, 11:31 PM IST | Pfizer Ltd. - Board Meeting Intimation for Board Meeting To Consider And Approve The Unaudited Financial Results For The Quar |
Pfizer Ltd. is a Public Limited Listed company incorporated on 21/11/1950 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L24231MH1950PLC008311 and registration number is 008311. Currently Company is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company's Total Operating Revenue is Rs. 2281.35 Cr. and Equity Capital is Rs. 45.75 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Pfizer is ₹5,157.25 as on Sep 16, 2025.
The Pfizer is operating in the Pharmaceuticals and health care Sector. It is classified as a Midcap stock on the BSE.
The market cap of Pfizer is ₹23,593.25 Cr as on Sep 16, 2025.
Today’s highest and lowest price of Pfizer are ₹5,182.00 and ₹5,124.30.
The 52-week high/low is the highest and lowest price at which Pfizer stock has traded in the past 52-week or nearly a year. The 52-week high of Pfizer is ₹6,120.00 and 52-week low of Pfizer is ₹3,742.90 as on Sep 16, 2025.
The Pfizer has shown returns of -0.13% over the past day, -10.46% for the past month, -12.2% over 3 months, -13.17% over 1 year, 7.16% across 3 years, and 0.62% over 5 years.
P/E ratio of and PB ratio of Pfizer are 29.18 and 5.59 on Sep 16, 2025. While the company gives a dividend yield of 3.20 per annum.